Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2

4(50.0%)

N/A

3(37.5%)

Phase 3

1(12.5%)

8Total

Phase 2(4)

N/A(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04773639Not ApplicableCompleted

Randomized Clinical Trial of a Multi-Modal Palliative Care Intervention

Role: collaborator

NCT03569657Not ApplicableCompleted

Activating Happiness in Cancer: A Positive Psychology Workshop for Patients, Survivors, and Caregivers

Role: collaborator

NCT02550925Not ApplicableCompleted

Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors

Role: collaborator

NCT01185132Phase 3Recruiting

Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

Role: lead

NCT01409473Phase 2Withdrawn

Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate Cancer

Role: lead

NCT01898962Phase 2Unknown

Definitive Therapy for Oligometastatic Solid Malignancies

Role: lead

NCT01185145Phase 2Unknown

Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy

Role: lead

NCT00390624Phase 2Completed

Prevention Of Nephrotoxicity Following Bone Marrow Transplantation Using Urodilatin and Mannitol

Role: lead

All 8 trials loaded